All Posts Tagged With: "ABMD"
(MDT) MedTech Industry Stock Outlook – March 2012 – Zacks Analyst Interviews
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure...
(MDT) MedTech Industry Stock Outlook – March 2012 – Industry Outlook
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure...
(ABMD) Abiomed Sees Positive USpella Device Data
Massachusetts-based cardiac assist devices maker Abiomed (ABMD) reported encouraging clinical data from the prophylactic use of its Impella 2.5 cardiac pumps in complex coronary interventions.
Results...
(MDT) Medical Technology Industry Stock Outlook – November 2011 – Industry Outlook
The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures,...
(MDT) Medical Devices Stock Outlook – Sept. 2011 – Industry Outlook
June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected...
(MDT) Medical Devices Stock Outlook – June 2011 – Industry Outlook
A host of macro headwinds (including price and procedure volume pressure) which hit the MedTech industry last year continued to haunt the sector during the March quarter and encumber growth. Although a number of these issues are expected to linger through the remainder of...
(MDT) Medical Devices Industry Outlook – April 2011 – Industry Outlook
Last year was challenging for medical device companies given the exigent economic conditions and an uncertain healthcare environment. The MedTech industry was hit by several macro headwinds in 2010 including price/volume and utilization pressure and a more restrictive regulatory...
(MDT) Medical Devices Industry Outlook December 2010 – Industry Outlook
Industry Dynamics
The global medical devices industry is fairly large, intensely competitive and highly innovative with 2009 worldwide sales in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into...
(ABMD) Abiomed’s Quarterly Loss Slightly Larger Than Expected
Abiomed Inc. (ABMD) reported a net loss of 13 cents per share for the fourth quarter fiscal 2010, marginally higher than the Zacks Consensus Estimate of a loss of 12 cents per share but lower than the...
(NEWS) Five stocks for Wednesday: March 3, 2010
On my blog Financial Tides I like to start out the day by screening on
4Mar2010 | Shawn | 0 comments | Continued(ABMD) Abiomed Beats Consensus Earnings Estimates
Abiomed, Inc. (ABMD) reported third quarter of fiscal 2010 results. For the quarter, net loss per share was 11 cents, beating the Zacks Consensus Estimate of loss per share of 18 cents and the year-ago loss...
(ABMD) Abiomed Reports Preliminary Results
Abiomed, Inc. (ABMD) reported preliminary results for the third quarter of fiscal 2010. Total revenues were roughly $22.8 million, an increase of 32% year over year and were at a record high. The company...
(ABMD) Abiomed, Inc’s Loss Narrower than Expected
Abiomed, Inc. (ABMD) reported fiscal second-quarter loss of 14 cents per share, considerably better than the Zacks Consensus Estimate of a loss of 21 cents. However, loss per...